Thank you for attending our learning activity; the feedback you provide here will be reviewed and used to improve future events. If you have any questions, please contact the CME Team at [email protected]. Commercial Bias Please share with us any evidence of commercial bias you may have witnessed. Each indication of bias will be investigated and handled accordingly by the CME Committee and Team per the ACCME Standards of Commercial Support. Did you witness any evidence of commercial bias at any point during the activity? * Yes No Please select the session(s) you witnessed the bias: * 1 2 3 Please explain in detail the bias that occurred during each session you witnessed it: * Activity Review As a result of participating in the Hepatitis C Intervention Symposium 2026 activity, learners will be able to...Identify areas for enhancement or scale up in your own HCV service deliveryUnderstand how a variety of interventions workIdentify suitable interventions to enhance HCV service deliveryDescribe how interventions can be implemented in your service settingAnalyze possible barriers to implementing interventions and how to overcome them Do you feel this activity fulfills its purpose as stated above? * Yes No Please describe how it did not: * Were your individual learning expectations for this activity met? * Yes No N/A Please describe how they were not met * Will you incorporate any changes into your practice/performance as a result of attending this activity? * Yes No N/A What changes will you make? * Why not? * The level of content in this CME activity was: (select one) * Too basic for my needs Appropriate for my learning needs Too advanced for my current level If you chose "Too basic..." or "Too advanced..." for the question above, please explain: Speaker Review Interactive Presentation: Nancy Reau, MD * Epidemiology of Hepatitis C and Testing and Treatment Options for Hepatitis C ExcellentGoodAveragePoorN/A Quality of the learning content: Quality of the learning content: - Excellent Quality of the learning content: - Good Quality of the learning content: - Average Quality of the learning content: - Poor Quality of the learning content: - N/A Presentation of the material: Presentation of the material: - Excellent Presentation of the material: - Good Presentation of the material: - Average Presentation of the material: - Poor Presentation of the material: - N/A Interactive Presentation-Andrew Aronsohn, MD, FAASLD * Interventions may include; Dried Blood Spot (DBS) Testing, Point-of-Care RNA Testing, Point-of-Care Antibody Testing, Care Navigation, Peer Support ExcellentGoodAveragePoorN/A Quality of the learning content: Quality of the learning content: - Excellent Quality of the learning content: - Good Quality of the learning content: - Average Quality of the learning content: - Poor Quality of the learning content: - N/A Presentation of the material: Presentation of the material: - Excellent Presentation of the material: - Good Presentation of the material: - Average Presentation of the material: - Poor Presentation of the material: - N/A Small Group Discussion Station 1-Maggie Kaufmann, MA/MPH * Integrated HCV care in drug treatment programs ExcellentGoodAveragePoorN/A Quality of the learning content: Quality of the learning content: - Excellent Quality of the learning content: - Good Quality of the learning content: - Average Quality of the learning content: - Poor Quality of the learning content: - N/A Presentation of the material: Presentation of the material: - Excellent Presentation of the material: - Good Presentation of the material: - Average Presentation of the material: - Poor Presentation of the material: - N/A Small Group Discussion Station 2-Sara Miranda * Reflex testing in low barrier addiction clinics ExcellentGoodAveragePoorN/A Quality of the learning content: Quality of the learning content: - Excellent Quality of the learning content: - Good Quality of the learning content: - Average Quality of the learning content: - Poor Quality of the learning content: - N/A Presentation of the material: Presentation of the material: - Excellent Presentation of the material: - Good Presentation of the material: - Average Presentation of the material: - Poor Presentation of the material: - N/A Small Group Discussion Station 3-Andrew Aronsohn, MD, FAASLD * Point-of-care HCV RNA testing ExcellentGoodAveragePoorN/A Quality of the learning content: Quality of the learning content: - Excellent Quality of the learning content: - Good Quality of the learning content: - Average Quality of the learning content: - Poor Quality of the learning content: - N/A Presentation of the material: Presentation of the material: - Excellent Presentation of the material: - Good Presentation of the material: - Average Presentation of the material: - Poor Presentation of the material: - N/A Small Group Discussion Station 4-Michelle Martin * Pharmacy models of HCV care ExcellentGoodAveragePoorN/A Quality of the learning content: Quality of the learning content: - Excellent Quality of the learning content: - Good Quality of the learning content: - Average Quality of the learning content: - Poor Quality of the learning content: - N/A Presentation of the material: Presentation of the material: - Excellent Presentation of the material: - Good Presentation of the material: - Average Presentation of the material: - Poor Presentation of the material: - N/A Small Group Discussion Station 5-Nancy Reau, MD * Test and treat algorithm in primary care clinics ExcellentGoodAveragePoorN/A Quality of the learning content: Quality of the learning content: - Excellent Quality of the learning content: - Good Quality of the learning content: - Average Quality of the learning content: - Poor Quality of the learning content: - N/A Presentation of the material: Presentation of the material: - Excellent Presentation of the material: - Good Presentation of the material: - Average Presentation of the material: - Poor Presentation of the material: - N/A Models of Care and Practical Support-Sara Miranda * Film screening of one of INHSU's Connecting with Care short films, showcasing successful models of HCV care Key features of a successful model of care Example of model of care and why it is successful ExcellentGoodAveragePoorN/A Quality of the learning content: Quality of the learning content: - Excellent Quality of the learning content: - Good Quality of the learning content: - Average Quality of the learning content: - Poor Quality of the learning content: - N/A Presentation of the material: Presentation of the material: - Excellent Presentation of the material: - Good Presentation of the material: - Average Presentation of the material: - Poor Presentation of the material: - N/A Where to From Here?-Olivia Dawson * Local resources, programs and training opportunities for ongoing HCV support Next steps, participant evaluations, workshop close ExcellentGoodAveragePoorN/A Quality of the learning content: Quality of the learning content: - Excellent Quality of the learning content: - Good Quality of the learning content: - Average Quality of the learning content: - Poor Quality of the learning content: - N/A Presentation of the material: Presentation of the material: - Excellent Presentation of the material: - Good Presentation of the material: - Average Presentation of the material: - Poor Presentation of the material: - N/A Final Thoughts What did you hope to gain or achieve by attending this activity? * Which aspects of this activity were most valuable to your practice? (Please be specific) * Which aspects of this activity could be strengthened or were less relevant to your practice? * What specific changes would enhance the educational value of this activity for future participants? * Do you face any barriers that keep you from changing your current practice/performance? * Yes No Please explain: * Please share any additional feedback you may have for the improvement of this activity or ideas you'd like to see in the future: Leave this field blank
